login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
MINK THERAPEUTICS INC (INKT) Stock News
USA
- NASDAQ:INKT -
US6036932019
-
Common Stock
14.5
USD
+0.16 (+1.12%)
Last: 9/25/2025, 11:49:47 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
INKT Latest News, Press Relases and Analysis
All
Press Releases
5 hours ago - By: MiNK Therapeutics
MiNK Therapeutics Dr. Jennifer Buell to Deliver Featured Plenary at 10th Annual CAR-TCR Summit in Boston, MA
5 hours ago - By: MiNK Therapeutics
MiNK Therapeutics Dr. Jennifer Buell to Deliver Featured Plenary at 10th Annual CAR-TCR Summit in Boston, MA
7 days ago - By: MiNK Therapeutics
MiNK Therapeutics Appoints Dr. Terese C. Hammond to Accelerate iNKT Pipeline to Pivotal Development
7 days ago - By: MiNK Therapeutics
MiNK Therapeutics Appoints Dr. Terese C. Hammond to Accelerate iNKT Pipeline to Pivotal Development
a month ago - By: Zacks Investment Research
- Mentions:
CSIQ
MNR
New Strong Sell Stocks for August 22nd
a month ago - By: The Motley Fool
MiNK Therapeutics Extends Cash Runway
a month ago - By: The Motley Fool
MiNK Therapeutics Cuts Q2 Cash Use 31%
a month ago - By: MiNK Therapeutics
MiNK Therapeutics Reports Clinical and Strategic Milestones and Second Quarter 2025 Results
a month ago - By: MiNK Therapeutics
MiNK Therapeutics Reports Clinical and Strategic Milestones and Second Quarter 2025 Results
2 months ago - By: MiNK Therapeutics
MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report
a month ago - By: Benzinga
- Mentions:
BTCM
DE
TIC
DFLI
...
Earnings Scheduled For August 14, 2025
2 months ago - By: MiNK Therapeutics
MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report
2 months ago - By: Benzinga
- Mentions:
CYCC
SLP
SSII
LIXT
...
12 Health Care Stocks Moving In Tuesday's Intraday Session
2 months ago - By: MiNK Therapeutics
MiNK Therapeutics Announces Frontiers in Immunology Publication Highlighting iNKT Cells as a Dual-Function Platform Key to Overcoming Barriers in Solid Tumor Cell Therapy
2 months ago - By: MiNK Therapeutics
MiNK Therapeutics Announces Frontiers in Immunology Publication Highlighting iNKT Cells as a Dual-Function Platform Key to Overcoming Barriers in Solid Tumor Cell Therapy
3 months ago - By: Stocktwits
- Mentions:
VTI
IWC
MiNK Therapeutics Stock Soars On Patient Receiving Full Remission In Testicular Cancer With Investigational Cell Therapy
Please enable JavaScript to continue using this application.